About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Birmingham Access to Care Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02525146

Birmingham Access to Care Study

The purpose of this study is to determine whether a modified form of the ARTAS (Antiretroviral Treatment and Access to Services) intervention, adapted for HIV patients who have fallen out of care, can...

Lead sponsor: University of Alabama at Birmingham•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Alabama at Birmingham

Collaborators

Birmingham AIDS Outreach
Johns Hopkins University
AIDS United

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•HIV patient with at least one primary care appointment since 1/1/10 but currently lost to follow-up defined as 1) currently out of care for greater than 7 months or 2) does NOT have two or more completed clinic visits separated by three or more months in time during a 12-month observation period (HRSA-HAB measure of retention in care) or 3) has 2 or more "no shows" - scheduled visits for which the patient has not arrived or canceled - in the past 12 months.
•19 years or older
•Be able and willing to provide informed consent
•Be willing to provide locator information
•Be willing to sign a HIPAA authorization form/medical record release form to facilitate medical record abstraction
•Report living in the vicinity
•Be able to communicate in English.
•Have significant cognitive or developmental impairment to the extent that they are unable to provide informed consent
•Incarcerated at the time of potential enrollment
•Are terminated via site PI decision

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

NCT06857071 · Undiagnosed HIV Infection, Populations That Are Reluctant to Test for HIV, and more

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.

NCT06900829 · HIV Infection, HIV, and more

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047 · HIV, HIV Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 9, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment170

Start dateSep 2013

Last updatedAug 9, 2016

Condition

HIV Infection HIV Care Loss to Followup

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions